Two of today's biggest analyst moves point in opposite directions. Truist raised its price target on GOOGL to $430, reaffirming Buy as AI-driven traffic growth keeps Alphabet firmly in favour. Piper Sandler went further on DELL, lifting its target to $497 — nearly tripling the prior figure — and upgrading the stock on the back of AI infrastructure demand. Meanwhile, Truist cut CZR to Hold with a $31 target, flagging consumer spending concerns in leisure.
MNKD scored a significant win today. The FDA approved Afrezza — its inhaled insulin — for children aged 6 and older. It's the first inhaled mealtime insulin cleared for pediatric use. Short interest sits at 10.1% of free float. Options depth is thin relative to the news scale, which could create rapid repricing.
Short pressure remains extreme on WOLF, where bears hold 131% of free float — up 20 points in a week. Shares to borrow have run dry. On the insider front, large sell filings dominated the week. Twilio saw a $184M block sale filed by a board-linked fund manager. The Walton family trimmed $251M in WMT stock. Ralph Lauren's founder sold $99.7M in RL shares. On the buy side, Capital Group disclosed a $285M purchase of ONC.
Retail dominates next week's earnings calendar. ULTA, DG, MDT, and M all report. Consumer spending signals from these names will set the tone heading into June.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
